Skip to Main Content

Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating because … well, you know … the predictable routine of online meetings and deadlines has resumed. Despite the tumult, the world keeps spinning. So please join us as we fire up the coffee kettle to brew a cup of needed stimulation and get on with the day. Toward that end, we have assembled a menu of tidbits. We hope your day goes well and, of course, do stay in touch. …

Merck (MRK) has become the latest big drug maker to plan to withhold discounts from the 340B federal drug discount program. The company sent notices to participating hospitals and clinics that discounts will be ended as of Sept. 21 if claims data is not provided from contract pharmacies, unless the hospital or clinic lacks its own in-house pharmacy. Several other drug makers have filed suit against the Department of Health and Human Services over its efforts to ensure the discounts are offered.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Create a display name to comment

This name will appear with your comment